SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-22-004883
Filing Date
2022-04-12
Accepted
2022-04-12 17:52:54
Documents
1
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 2056
  Complete submission text file 0001654954-22-004883.txt   3789
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS INC. 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34600 | Film No.: 22823183